Robert Weisman reports on biotech and life sciences. In more than two decades at The Globe, he has been a technology editor and a business writer covering high-tech, venture capital, aerospace, management, hospitals, and health care. Most recently, he wrote about baby boomers, aging, and generational change for the metro desk. He's also covered the COVID-19 vaccine rollout and the pandemic's impact on senior care. Before joining The Globe, he was a business editor and writer for the Seattle Times, Hartford Courant, and New Haven Register. He is a native of Norwich, Conn., and a graduate of Boston University.